Augmentin Dosing for Newborns (0-28 Days)
Augmentin is NOT routinely recommended for newborns from birth, and specific neonatal dosing guidelines are not established in major pediatric infectious disease guidelines. For neonates requiring β-lactam/β-lactamase inhibitor therapy, alternative agents with established neonatal dosing are preferred.
Neonatal Antibiotic Alternatives with Established Dosing
When β-lactam/β-lactamase inhibitor coverage is needed in neonates, ampicillin-sulbactam is the preferred agent with the following dosing 1:
- Ampicillin-sulbactam: 200 mg/kg/day of ampicillin component, divided every 6 hours 1
For specific neonatal infections requiring broad-spectrum coverage 1:
- Necrotizing enterocolitis: Ampicillin + gentamicin + metronidazole, or ampicillin + cefotaxime + metronidazole, or meropenem 1
- Complicated intra-abdominal infections: Ampicillin-sulbactam 200 mg/kg/day every 6 hours 1
Piperacillin-Tazobactam as Alternative
If piperacillin-tazobactam is considered 2:
- Postmenstrual age ≤30 weeks: 100 mg/kg/dose IV every 8 hours (of piperacillin component) 2
- Postmenstrual age >30 weeks: 80 mg/kg/dose IV every 6 hours (of piperacillin component) 2
Critical Considerations for Neonatal Dosing
Renal function is immature in neonates, requiring careful dose adjustment 2:
- Gestational age and postnatal age significantly affect drug clearance 2
- Cystatin C levels and renal maturation must be considered 3
- Augmented renal clearance in critically ill neonates may require more frequent dosing 3
Why Augmentin Is Not Standard in Neonates
The amoxicillin-clavulanate combination lacks:
- Established pharmacokinetic data in neonates <3 months 4, 5
- FDA approval for use in newborns 6, 7
- Guideline-based dosing recommendations for the 0-28 day age group 1, 2
For infants ≥3 months requiring amoxicillin-clavulanate, standard dosing begins at 45 mg/kg/day divided every 12 hours for mild infections, or 90 mg/kg/day divided every 12 hours for severe infections or high-resistance areas 4, 5.
Common Pitfall to Avoid
Never extrapolate pediatric or infant dosing to neonates due to immature renal function, altered volume of distribution, and prolonged elimination half-lives in this age group 3, 8. Always consult pediatric infectious disease specialists when β-lactam/β-lactamase inhibitor therapy is considered essential in a neonate.